| 10.77 0.05 (0.47%) | 12-15 15:59 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 12.6 | 1-year : | 14.71 |
| Resists | First : | 10.78 | Second : | 12.6 |
| Pivot price | 10.74 | |||
| Supports | First : | 10.67 | Second : | 10.6 |
| MAs | MA(5) : | 10.74 | MA(20) : | 10.75  |
| MA(100) : | 10.66 |
MA(250) : | 0 | |
| MACD | MACD : | 0 |
Signal : | 0 |
| %K %D | K(14,3) : | 55 |
D(3) : | 39.2 |
| RSI | RSI(14): 54.6 |
|||
| 52-week | High : | 10.85 | Low : | 10.22 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.[ RFAI ] has closed below upper band by 27.3%. Bollinger Bands are 31.8% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 10.78 - 10.86 | 10.86 - 10.91 |
| Low: | 10.58 - 10.66 | 10.66 - 10.72 |
| Close: | 10.66 - 10.79 | 10.79 - 10.89 |
RF Acquisition Corp II does not have significant operations. The company intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. It intends to focus its search for a business combination on target businesses in the technology sector, including artificial intelligence, quantum computing, and biotechnology in Asia. The company was incorporated in 2024 and is based in Singapore.
Thu, 02 Oct 2025
$19.5B Market Opportunity: AI Drug Discovery Pioneer Nanyang Biologics Goes Public in $1.5B SPAC Deal - Stock Titan
Wed, 16 Sep 2020
NCTY - The9 Ltd Latest Stock News & Market Updates - Stock Titan
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Outperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Financial Services
|
|
|
Industry:
Shell Companies
|
|
| Shares Out | 15 (M) |
| Shares Float | 11 (M) |
| Held by Insiders | 19.1 (%) |
| Held by Institutions | 69.3 (%) |
| Shares Short | 2 (K) |
| Shares Short P.Month | 0 (K) |
| EPS | 0.17 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | -0.26 |
| Profit Margin | 0 % |
| Operating Margin | 0 % |
| Return on Assets (ttm) | 0 % |
| Return on Equity (ttm) | 0 % |
| Qtrly Rev. Growth | 0 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 0 |
| EBITDA (p.s.) | 0 |
| Qtrly Earnings Growth | -25.8 % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | 0 (M) |
| PE Ratio | 63.35 |
| PEG Ratio | 0 |
| Price to Book value | -41.43 |
| Price to Sales | 0 |
| Price to Cash Flow | -374.07 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|